Breakthrough in Nanotechnology: Novel Hydrogel Formulations Offer Promising Therapy for Atopic Dermatitis

Researchers from the UiT The Arctic University of Norway have made significant strides in developing a novel therapeutic strategy for atopic dermatitis (AD), a chronic inflammatory skin disease that affects millions of people worldwide. The study proposes a novel hydrogel formulation that utilizes lipid nanoparticles with a model drug, betamethasone dipropionate (BMS), incorporated in a gel formulation comprising a natural emollient, coconut oil. This breakthrough may offer a more effective and safer treatment option for patients suffering from AD.

Key Takeaways:

• The novel hydrogel formulations, consisting of lipid nanoparticles and natural emollients, were found to prolong the release of BMS up to 24 hours.
• Preliminary in vitro and ex vivo studies demonstrated the safety and efficacy of the formulations, which were found to be non-toxic and stable.
• The research suggests that this novel therapeutic strategy may offer a more effective treatment option for AD, with superior therapeutic outcomes and acceptability compared to existing treatments.
• The study was conducted by a team of researchers led by Maddhusja Nalliah from the Dermatoplastic Imaging Research Group, Dept. of Clinical Medicine, Arctic University of Norway (UiT).
• The research involved the development of three different hydrogel formulations, each incorporating different hydrogel-forming materials: chitosan, alginate, and carbomer.
• The study highlighted the importance of using natural emollients, such as coconut oil, in the formulation to enhance therapeutic outcomes.

Statistics:

• The researchers found that the novel hydrogel formulations prolonged the release of BMS up to 24 hours.
• The study involved the development of three different hydrogel formulations, each with a unique combination of hydrogel-forming materials.
• The researchers conducted in vitro and ex vivo studies to assess the safety and efficacy of the formulations, which demonstrated promising results.

Sources:

• Sustained Release of Betamethasone from Solid Lipid Nanoparticles Loaded Polymeric Hydrogels with Natural Emollient: One Step Closer to Effective Topical Therapy for Atopic Dermatitis. Journal of Pharmaceutical Sciences, 2025:103876.
• UiT The Arctic University of Norway Reports Findings in Nanoparticles (Sustained Release of Betamethasone from Solid Lipid Nanoparticles Loaded Polymeric Hydrogels with Natural Emollient: One Step Closer to Effective Topical Therapy for Atopic ...). Nanotechnology Weekly. June 30, 2025; p 3640.